Medical Care
Global Monkeypox Treatment Market Research Report 2025
- May 05, 25
- ID: 228480
- Pages: 88
- Figures: 89
- Views: 10
The global market for Monkeypox Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.
North American market for Monkeypox Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Monkeypox Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Monkeypox Treatment in Hospital Pharmacy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Monkeypox Treatment include Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd., Mylan N.V., Olon S.p.A., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Monkeypox Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Treatment.
The Monkeypox Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monkeypox Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monkeypox Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Segment by Type
Oral
Injectable
Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monkeypox Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.
North American market for Monkeypox Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Monkeypox Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Monkeypox Treatment in Hospital Pharmacy is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Monkeypox Treatment include Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd., Mylan N.V., Olon S.p.A., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Monkeypox Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Treatment.
The Monkeypox Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monkeypox Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monkeypox Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bavarian Nordic
Chimerix, Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Segment by Type
Oral
Injectable
Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monkeypox Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monkeypox Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injectable
1.3 Market by Application
1.3.1 Global Monkeypox Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monkeypox Treatment Market Perspective (2020-2031)
2.2 Global Monkeypox Treatment Growth Trends by Region
2.2.1 Global Monkeypox Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monkeypox Treatment Historic Market Size by Region (2020-2025)
2.2.3 Monkeypox Treatment Forecasted Market Size by Region (2026-2031)
2.3 Monkeypox Treatment Market Dynamics
2.3.1 Monkeypox Treatment Industry Trends
2.3.2 Monkeypox Treatment Market Drivers
2.3.3 Monkeypox Treatment Market Challenges
2.3.4 Monkeypox Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monkeypox Treatment Players by Revenue
3.1.1 Global Top Monkeypox Treatment Players by Revenue (2020-2025)
3.1.2 Global Monkeypox Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Monkeypox Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monkeypox Treatment Revenue
3.4 Global Monkeypox Treatment Market Concentration Ratio
3.4.1 Global Monkeypox Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monkeypox Treatment Revenue in 2024
3.5 Global Key Players of Monkeypox Treatment Head office and Area Served
3.6 Global Key Players of Monkeypox Treatment, Product and Application
3.7 Global Key Players of Monkeypox Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monkeypox Treatment Breakdown Data by Type
4.1 Global Monkeypox Treatment Historic Market Size by Type (2020-2025)
4.2 Global Monkeypox Treatment Forecasted Market Size by Type (2026-2031)
5 Monkeypox Treatment Breakdown Data by Application
5.1 Global Monkeypox Treatment Historic Market Size by Application (2020-2025)
5.2 Global Monkeypox Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monkeypox Treatment Market Size (2020-2031)
6.2 North America Monkeypox Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monkeypox Treatment Market Size by Country (2020-2025)
6.4 North America Monkeypox Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monkeypox Treatment Market Size (2020-2031)
7.2 Europe Monkeypox Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monkeypox Treatment Market Size by Country (2020-2025)
7.4 Europe Monkeypox Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Treatment Market Size (2020-2031)
8.2 Asia-Pacific Monkeypox Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monkeypox Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Monkeypox Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monkeypox Treatment Market Size (2020-2031)
9.2 Latin America Monkeypox Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monkeypox Treatment Market Size by Country (2020-2025)
9.4 Latin America Monkeypox Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Treatment Market Size (2020-2031)
10.2 Middle East & Africa Monkeypox Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monkeypox Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Monkeypox Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Company Details
11.1.2 Bavarian Nordic Business Overview
11.1.3 Bavarian Nordic Monkeypox Treatment Introduction
11.1.4 Bavarian Nordic Revenue in Monkeypox Treatment Business (2020-2025)
11.1.5 Bavarian Nordic Recent Development
11.2 Chimerix, Inc.
11.2.1 Chimerix, Inc. Company Details
11.2.2 Chimerix, Inc. Business Overview
11.2.3 Chimerix, Inc. Monkeypox Treatment Introduction
11.2.4 Chimerix, Inc. Revenue in Monkeypox Treatment Business (2020-2025)
11.2.5 Chimerix, Inc. Recent Development
11.3 CIDIC Company Limited
11.3.1 CIDIC Company Limited Company Details
11.3.2 CIDIC Company Limited Business Overview
11.3.3 CIDIC Company Limited Monkeypox Treatment Introduction
11.3.4 CIDIC Company Limited Revenue in Monkeypox Treatment Business (2020-2025)
11.3.5 CIDIC Company Limited Recent Development
11.4 Emcure Pharmaceuticals
11.4.1 Emcure Pharmaceuticals Company Details
11.4.2 Emcure Pharmaceuticals Business Overview
11.4.3 Emcure Pharmaceuticals Monkeypox Treatment Introduction
11.4.4 Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2020-2025)
11.4.5 Emcure Pharmaceuticals Recent Development
11.5 Emergent
11.5.1 Emergent Company Details
11.5.2 Emergent Business Overview
11.5.3 Emergent Monkeypox Treatment Introduction
11.5.4 Emergent Revenue in Monkeypox Treatment Business (2020-2025)
11.5.5 Emergent Recent Development
11.6 Gilead Sciences Inc.
11.6.1 Gilead Sciences Inc. Company Details
11.6.2 Gilead Sciences Inc. Business Overview
11.6.3 Gilead Sciences Inc. Monkeypox Treatment Introduction
11.6.4 Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2020-2025)
11.6.5 Gilead Sciences Inc. Recent Development
11.7 Hetero Drugs Limited
11.7.1 Hetero Drugs Limited Company Details
11.7.2 Hetero Drugs Limited Business Overview
11.7.3 Hetero Drugs Limited Monkeypox Treatment Introduction
11.7.4 Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2020-2025)
11.7.5 Hetero Drugs Limited Recent Development
11.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
11.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Details
11.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
11.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Introduction
11.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2020-2025)
11.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Details
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Monkeypox Treatment Introduction
11.9.4 Mylan N.V. Revenue in Monkeypox Treatment Business (2020-2025)
11.9.5 Mylan N.V. Recent Development
11.10 Olon S.p.A.
11.10.1 Olon S.p.A. Company Details
11.10.2 Olon S.p.A. Business Overview
11.10.3 Olon S.p.A. Monkeypox Treatment Introduction
11.10.4 Olon S.p.A. Revenue in Monkeypox Treatment Business (2020-2025)
11.10.5 Olon S.p.A. Recent Development
11.11 Piramal Pharma Solutions
11.11.1 Piramal Pharma Solutions Company Details
11.11.2 Piramal Pharma Solutions Business Overview
11.11.3 Piramal Pharma Solutions Monkeypox Treatment Introduction
11.11.4 Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2020-2025)
11.11.5 Piramal Pharma Solutions Recent Development
11.12 SIGA Technologies Inc.
11.12.1 SIGA Technologies Inc. Company Details
11.12.2 SIGA Technologies Inc. Business Overview
11.12.3 SIGA Technologies Inc. Monkeypox Treatment Introduction
11.12.4 SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2020-2025)
11.12.5 SIGA Technologies Inc. Recent Development
11.13 Sonofi SA
11.13.1 Sonofi SA Company Details
11.13.2 Sonofi SA Business Overview
11.13.3 Sonofi SA Monkeypox Treatment Introduction
11.13.4 Sonofi SA Revenue in Monkeypox Treatment Business (2020-2025)
11.13.5 Sonofi SA Recent Development
11.14 Teva Pharmaceutical Industries Limited
11.14.1 Teva Pharmaceutical Industries Limited Company Details
11.14.2 Teva Pharmaceutical Industries Limited Business Overview
11.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Introduction
11.14.4 Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2020-2025)
11.14.5 Teva Pharmaceutical Industries Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monkeypox Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injectable
1.3 Market by Application
1.3.1 Global Monkeypox Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monkeypox Treatment Market Perspective (2020-2031)
2.2 Global Monkeypox Treatment Growth Trends by Region
2.2.1 Global Monkeypox Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Monkeypox Treatment Historic Market Size by Region (2020-2025)
2.2.3 Monkeypox Treatment Forecasted Market Size by Region (2026-2031)
2.3 Monkeypox Treatment Market Dynamics
2.3.1 Monkeypox Treatment Industry Trends
2.3.2 Monkeypox Treatment Market Drivers
2.3.3 Monkeypox Treatment Market Challenges
2.3.4 Monkeypox Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monkeypox Treatment Players by Revenue
3.1.1 Global Top Monkeypox Treatment Players by Revenue (2020-2025)
3.1.2 Global Monkeypox Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Monkeypox Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Monkeypox Treatment Revenue
3.4 Global Monkeypox Treatment Market Concentration Ratio
3.4.1 Global Monkeypox Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monkeypox Treatment Revenue in 2024
3.5 Global Key Players of Monkeypox Treatment Head office and Area Served
3.6 Global Key Players of Monkeypox Treatment, Product and Application
3.7 Global Key Players of Monkeypox Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monkeypox Treatment Breakdown Data by Type
4.1 Global Monkeypox Treatment Historic Market Size by Type (2020-2025)
4.2 Global Monkeypox Treatment Forecasted Market Size by Type (2026-2031)
5 Monkeypox Treatment Breakdown Data by Application
5.1 Global Monkeypox Treatment Historic Market Size by Application (2020-2025)
5.2 Global Monkeypox Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Monkeypox Treatment Market Size (2020-2031)
6.2 North America Monkeypox Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Monkeypox Treatment Market Size by Country (2020-2025)
6.4 North America Monkeypox Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Monkeypox Treatment Market Size (2020-2031)
7.2 Europe Monkeypox Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Monkeypox Treatment Market Size by Country (2020-2025)
7.4 Europe Monkeypox Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Monkeypox Treatment Market Size (2020-2031)
8.2 Asia-Pacific Monkeypox Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Monkeypox Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Monkeypox Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Monkeypox Treatment Market Size (2020-2031)
9.2 Latin America Monkeypox Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Monkeypox Treatment Market Size by Country (2020-2025)
9.4 Latin America Monkeypox Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monkeypox Treatment Market Size (2020-2031)
10.2 Middle East & Africa Monkeypox Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Monkeypox Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Monkeypox Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Company Details
11.1.2 Bavarian Nordic Business Overview
11.1.3 Bavarian Nordic Monkeypox Treatment Introduction
11.1.4 Bavarian Nordic Revenue in Monkeypox Treatment Business (2020-2025)
11.1.5 Bavarian Nordic Recent Development
11.2 Chimerix, Inc.
11.2.1 Chimerix, Inc. Company Details
11.2.2 Chimerix, Inc. Business Overview
11.2.3 Chimerix, Inc. Monkeypox Treatment Introduction
11.2.4 Chimerix, Inc. Revenue in Monkeypox Treatment Business (2020-2025)
11.2.5 Chimerix, Inc. Recent Development
11.3 CIDIC Company Limited
11.3.1 CIDIC Company Limited Company Details
11.3.2 CIDIC Company Limited Business Overview
11.3.3 CIDIC Company Limited Monkeypox Treatment Introduction
11.3.4 CIDIC Company Limited Revenue in Monkeypox Treatment Business (2020-2025)
11.3.5 CIDIC Company Limited Recent Development
11.4 Emcure Pharmaceuticals
11.4.1 Emcure Pharmaceuticals Company Details
11.4.2 Emcure Pharmaceuticals Business Overview
11.4.3 Emcure Pharmaceuticals Monkeypox Treatment Introduction
11.4.4 Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2020-2025)
11.4.5 Emcure Pharmaceuticals Recent Development
11.5 Emergent
11.5.1 Emergent Company Details
11.5.2 Emergent Business Overview
11.5.3 Emergent Monkeypox Treatment Introduction
11.5.4 Emergent Revenue in Monkeypox Treatment Business (2020-2025)
11.5.5 Emergent Recent Development
11.6 Gilead Sciences Inc.
11.6.1 Gilead Sciences Inc. Company Details
11.6.2 Gilead Sciences Inc. Business Overview
11.6.3 Gilead Sciences Inc. Monkeypox Treatment Introduction
11.6.4 Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2020-2025)
11.6.5 Gilead Sciences Inc. Recent Development
11.7 Hetero Drugs Limited
11.7.1 Hetero Drugs Limited Company Details
11.7.2 Hetero Drugs Limited Business Overview
11.7.3 Hetero Drugs Limited Monkeypox Treatment Introduction
11.7.4 Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2020-2025)
11.7.5 Hetero Drugs Limited Recent Development
11.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
11.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Details
11.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
11.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Introduction
11.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2020-2025)
11.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Development
11.9 Mylan N.V.
11.9.1 Mylan N.V. Company Details
11.9.2 Mylan N.V. Business Overview
11.9.3 Mylan N.V. Monkeypox Treatment Introduction
11.9.4 Mylan N.V. Revenue in Monkeypox Treatment Business (2020-2025)
11.9.5 Mylan N.V. Recent Development
11.10 Olon S.p.A.
11.10.1 Olon S.p.A. Company Details
11.10.2 Olon S.p.A. Business Overview
11.10.3 Olon S.p.A. Monkeypox Treatment Introduction
11.10.4 Olon S.p.A. Revenue in Monkeypox Treatment Business (2020-2025)
11.10.5 Olon S.p.A. Recent Development
11.11 Piramal Pharma Solutions
11.11.1 Piramal Pharma Solutions Company Details
11.11.2 Piramal Pharma Solutions Business Overview
11.11.3 Piramal Pharma Solutions Monkeypox Treatment Introduction
11.11.4 Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2020-2025)
11.11.5 Piramal Pharma Solutions Recent Development
11.12 SIGA Technologies Inc.
11.12.1 SIGA Technologies Inc. Company Details
11.12.2 SIGA Technologies Inc. Business Overview
11.12.3 SIGA Technologies Inc. Monkeypox Treatment Introduction
11.12.4 SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2020-2025)
11.12.5 SIGA Technologies Inc. Recent Development
11.13 Sonofi SA
11.13.1 Sonofi SA Company Details
11.13.2 Sonofi SA Business Overview
11.13.3 Sonofi SA Monkeypox Treatment Introduction
11.13.4 Sonofi SA Revenue in Monkeypox Treatment Business (2020-2025)
11.13.5 Sonofi SA Recent Development
11.14 Teva Pharmaceutical Industries Limited
11.14.1 Teva Pharmaceutical Industries Limited Company Details
11.14.2 Teva Pharmaceutical Industries Limited Business Overview
11.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Introduction
11.14.4 Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2020-2025)
11.14.5 Teva Pharmaceutical Industries Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Monkeypox Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Global Monkeypox Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Monkeypox Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Monkeypox Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Monkeypox Treatment Market Share by Region (2020-2025)
Table 8. Global Monkeypox Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Monkeypox Treatment Market Share by Region (2026-2031)
Table 10. Monkeypox Treatment Market Trends
Table 11. Monkeypox Treatment Market Drivers
Table 12. Monkeypox Treatment Market Challenges
Table 13. Monkeypox Treatment Market Restraints
Table 14. Global Monkeypox Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Monkeypox Treatment Market Share by Players (2020-2025)
Table 16. Global Top Monkeypox Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2024)
Table 17. Ranking of Global Top Monkeypox Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Monkeypox Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Monkeypox Treatment, Headquarters and Area Served
Table 20. Global Key Players of Monkeypox Treatment, Product and Application
Table 21. Global Key Players of Monkeypox Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monkeypox Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Monkeypox Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Monkeypox Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Monkeypox Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Monkeypox Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Monkeypox Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Monkeypox Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Monkeypox Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Monkeypox Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Monkeypox Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Monkeypox Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Monkeypox Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Monkeypox Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Monkeypox Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Monkeypox Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Monkeypox Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Monkeypox Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Monkeypox Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Monkeypox Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bavarian Nordic Company Details
Table 47. Bavarian Nordic Business Overview
Table 48. Bavarian Nordic Monkeypox Treatment Product
Table 49. Bavarian Nordic Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 50. Bavarian Nordic Recent Development
Table 51. Chimerix, Inc. Company Details
Table 52. Chimerix, Inc. Business Overview
Table 53. Chimerix, Inc. Monkeypox Treatment Product
Table 54. Chimerix, Inc. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 55. Chimerix, Inc. Recent Development
Table 56. CIDIC Company Limited Company Details
Table 57. CIDIC Company Limited Business Overview
Table 58. CIDIC Company Limited Monkeypox Treatment Product
Table 59. CIDIC Company Limited Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 60. CIDIC Company Limited Recent Development
Table 61. Emcure Pharmaceuticals Company Details
Table 62. Emcure Pharmaceuticals Business Overview
Table 63. Emcure Pharmaceuticals Monkeypox Treatment Product
Table 64. Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 65. Emcure Pharmaceuticals Recent Development
Table 66. Emergent Company Details
Table 67. Emergent Business Overview
Table 68. Emergent Monkeypox Treatment Product
Table 69. Emergent Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 70. Emergent Recent Development
Table 71. Gilead Sciences Inc. Company Details
Table 72. Gilead Sciences Inc. Business Overview
Table 73. Gilead Sciences Inc. Monkeypox Treatment Product
Table 74. Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 75. Gilead Sciences Inc. Recent Development
Table 76. Hetero Drugs Limited Company Details
Table 77. Hetero Drugs Limited Business Overview
Table 78. Hetero Drugs Limited Monkeypox Treatment Product
Table 79. Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 80. Hetero Drugs Limited Recent Development
Table 81. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Details
Table 82. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
Table 83. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Product
Table 84. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 85. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Development
Table 86. Mylan N.V. Company Details
Table 87. Mylan N.V. Business Overview
Table 88. Mylan N.V. Monkeypox Treatment Product
Table 89. Mylan N.V. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 90. Mylan N.V. Recent Development
Table 91. Olon S.p.A. Company Details
Table 92. Olon S.p.A. Business Overview
Table 93. Olon S.p.A. Monkeypox Treatment Product
Table 94. Olon S.p.A. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 95. Olon S.p.A. Recent Development
Table 96. Piramal Pharma Solutions Company Details
Table 97. Piramal Pharma Solutions Business Overview
Table 98. Piramal Pharma Solutions Monkeypox Treatment Product
Table 99. Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 100. Piramal Pharma Solutions Recent Development
Table 101. SIGA Technologies Inc. Company Details
Table 102. SIGA Technologies Inc. Business Overview
Table 103. SIGA Technologies Inc. Monkeypox Treatment Product
Table 104. SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 105. SIGA Technologies Inc. Recent Development
Table 106. Sonofi SA Company Details
Table 107. Sonofi SA Business Overview
Table 108. Sonofi SA Monkeypox Treatment Product
Table 109. Sonofi SA Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 110. Sonofi SA Recent Development
Table 111. Teva Pharmaceutical Industries Limited Company Details
Table 112. Teva Pharmaceutical Industries Limited Business Overview
Table 113. Teva Pharmaceutical Industries Limited Monkeypox Treatment Product
Table 114. Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 115. Teva Pharmaceutical Industries Limited Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Monkeypox Treatment Picture
Figure 2. Global Monkeypox Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Monkeypox Treatment Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Injectable Features
Figure 6. Global Monkeypox Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Monkeypox Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Monkeypox Treatment Report Years Considered
Figure 12. Global Monkeypox Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Monkeypox Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Monkeypox Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Monkeypox Treatment Market Share by Players in 2024
Figure 16. Global Top Monkeypox Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Monkeypox Treatment Revenue in 2024
Figure 18. North America Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Monkeypox Treatment Market Share by Country (2020-2031)
Figure 20. United States Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Monkeypox Treatment Market Share by Country (2020-2031)
Figure 24. Germany Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Monkeypox Treatment Market Share by Region (2020-2031)
Figure 32. China Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Monkeypox Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Monkeypox Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bavarian Nordic Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 48. Chimerix, Inc. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 49. CIDIC Company Limited Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 50. Emcure Pharmaceuticals Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 51. Emergent Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 52. Gilead Sciences Inc. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 53. Hetero Drugs Limited Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 54. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 55. Mylan N.V. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 56. Olon S.p.A. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 57. Piramal Pharma Solutions Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 58. SIGA Technologies Inc. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 59. Sonofi SA Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 60. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Monkeypox Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Injectable
Table 4. Global Monkeypox Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Monkeypox Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Monkeypox Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Monkeypox Treatment Market Share by Region (2020-2025)
Table 8. Global Monkeypox Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Monkeypox Treatment Market Share by Region (2026-2031)
Table 10. Monkeypox Treatment Market Trends
Table 11. Monkeypox Treatment Market Drivers
Table 12. Monkeypox Treatment Market Challenges
Table 13. Monkeypox Treatment Market Restraints
Table 14. Global Monkeypox Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Monkeypox Treatment Market Share by Players (2020-2025)
Table 16. Global Top Monkeypox Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2024)
Table 17. Ranking of Global Top Monkeypox Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Monkeypox Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Monkeypox Treatment, Headquarters and Area Served
Table 20. Global Key Players of Monkeypox Treatment, Product and Application
Table 21. Global Key Players of Monkeypox Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monkeypox Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Monkeypox Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Monkeypox Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Monkeypox Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Monkeypox Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Monkeypox Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Monkeypox Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Monkeypox Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Monkeypox Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Monkeypox Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Monkeypox Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Monkeypox Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Monkeypox Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Monkeypox Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Monkeypox Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Monkeypox Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Monkeypox Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Monkeypox Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Monkeypox Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Monkeypox Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bavarian Nordic Company Details
Table 47. Bavarian Nordic Business Overview
Table 48. Bavarian Nordic Monkeypox Treatment Product
Table 49. Bavarian Nordic Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 50. Bavarian Nordic Recent Development
Table 51. Chimerix, Inc. Company Details
Table 52. Chimerix, Inc. Business Overview
Table 53. Chimerix, Inc. Monkeypox Treatment Product
Table 54. Chimerix, Inc. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 55. Chimerix, Inc. Recent Development
Table 56. CIDIC Company Limited Company Details
Table 57. CIDIC Company Limited Business Overview
Table 58. CIDIC Company Limited Monkeypox Treatment Product
Table 59. CIDIC Company Limited Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 60. CIDIC Company Limited Recent Development
Table 61. Emcure Pharmaceuticals Company Details
Table 62. Emcure Pharmaceuticals Business Overview
Table 63. Emcure Pharmaceuticals Monkeypox Treatment Product
Table 64. Emcure Pharmaceuticals Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 65. Emcure Pharmaceuticals Recent Development
Table 66. Emergent Company Details
Table 67. Emergent Business Overview
Table 68. Emergent Monkeypox Treatment Product
Table 69. Emergent Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 70. Emergent Recent Development
Table 71. Gilead Sciences Inc. Company Details
Table 72. Gilead Sciences Inc. Business Overview
Table 73. Gilead Sciences Inc. Monkeypox Treatment Product
Table 74. Gilead Sciences Inc. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 75. Gilead Sciences Inc. Recent Development
Table 76. Hetero Drugs Limited Company Details
Table 77. Hetero Drugs Limited Business Overview
Table 78. Hetero Drugs Limited Monkeypox Treatment Product
Table 79. Hetero Drugs Limited Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 80. Hetero Drugs Limited Recent Development
Table 81. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Details
Table 82. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Business Overview
Table 83. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Product
Table 84. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 85. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Recent Development
Table 86. Mylan N.V. Company Details
Table 87. Mylan N.V. Business Overview
Table 88. Mylan N.V. Monkeypox Treatment Product
Table 89. Mylan N.V. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 90. Mylan N.V. Recent Development
Table 91. Olon S.p.A. Company Details
Table 92. Olon S.p.A. Business Overview
Table 93. Olon S.p.A. Monkeypox Treatment Product
Table 94. Olon S.p.A. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 95. Olon S.p.A. Recent Development
Table 96. Piramal Pharma Solutions Company Details
Table 97. Piramal Pharma Solutions Business Overview
Table 98. Piramal Pharma Solutions Monkeypox Treatment Product
Table 99. Piramal Pharma Solutions Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 100. Piramal Pharma Solutions Recent Development
Table 101. SIGA Technologies Inc. Company Details
Table 102. SIGA Technologies Inc. Business Overview
Table 103. SIGA Technologies Inc. Monkeypox Treatment Product
Table 104. SIGA Technologies Inc. Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 105. SIGA Technologies Inc. Recent Development
Table 106. Sonofi SA Company Details
Table 107. Sonofi SA Business Overview
Table 108. Sonofi SA Monkeypox Treatment Product
Table 109. Sonofi SA Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 110. Sonofi SA Recent Development
Table 111. Teva Pharmaceutical Industries Limited Company Details
Table 112. Teva Pharmaceutical Industries Limited Business Overview
Table 113. Teva Pharmaceutical Industries Limited Monkeypox Treatment Product
Table 114. Teva Pharmaceutical Industries Limited Revenue in Monkeypox Treatment Business (2020-2025) & (US$ Million)
Table 115. Teva Pharmaceutical Industries Limited Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Monkeypox Treatment Picture
Figure 2. Global Monkeypox Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Monkeypox Treatment Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Injectable Features
Figure 6. Global Monkeypox Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Monkeypox Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Monkeypox Treatment Report Years Considered
Figure 12. Global Monkeypox Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Monkeypox Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Monkeypox Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Monkeypox Treatment Market Share by Players in 2024
Figure 16. Global Top Monkeypox Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monkeypox Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Monkeypox Treatment Revenue in 2024
Figure 18. North America Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Monkeypox Treatment Market Share by Country (2020-2031)
Figure 20. United States Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Monkeypox Treatment Market Share by Country (2020-2031)
Figure 24. Germany Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Monkeypox Treatment Market Share by Region (2020-2031)
Figure 32. China Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Monkeypox Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Monkeypox Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Monkeypox Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bavarian Nordic Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 48. Chimerix, Inc. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 49. CIDIC Company Limited Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 50. Emcure Pharmaceuticals Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 51. Emergent Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 52. Gilead Sciences Inc. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 53. Hetero Drugs Limited Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 54. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 55. Mylan N.V. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 56. Olon S.p.A. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 57. Piramal Pharma Solutions Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 58. SIGA Technologies Inc. Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 59. Sonofi SA Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 60. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Monkeypox Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Double-handle Kitchen Mixer Tap Market Research Report 2025
Jul 24, 25
Global Kitchen Mixer Tap Market Research Report 2025
Jul 24, 25
Global Kitchen Collection Market Research Report 2025
Jul 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232